S Kopersztych, MT Rezkallah, SS Miki, CK … - CA A Cancer Journal … - interscience.wiley.com Cell-mediated immunity (CMI) was evaluated in 82 patients with non-lymphoid tumors by in vivo
and in vitro methods. These included skin test with ubiquitous antigens, 2,4 dinitrochlorobenzene
(DNCB) sensitization, determination of T and B peripheral blood lymphocytes, and ... Cited by 37 - Related articles - All 2 versions
AR Ahmed, DA Blose - Archives of Dermatology, 1983 - archderm.highwire.org Page 1. Delayed-Type Hypersensitivity Skin Testing A Review A. Razzaque Ahmed, MD,
Douglas A. Blose, MD \s=b\ Delayed hypersensitivity skin testing is based on the reaction
that occurs in response to the intradermal injection of an antigen. The ... Cited by 37 - Related articles - All 4 versions
- ►nih.gov [PDF] HA Reimann - Archives of Internal Medicine, 1957 - archinte.highwire.org In this 22d annual review, as usual, sub- jects of current importance have the most space. Antimicrobic
therapy with its less desirable aspects and viral diseases come first. Bacillary infections, especially
from Salmonella and Mycobacterium, hold wide interest. Infections of coccal origin, ... Cited by 25 - Related articles - All 14 versions
L Palma, N Di Lorenzo, B Guidetti - Journal of Neurosurgery, 1978 - thejns.org The correlation existing in several human malignancies between lymphocytic infiltration and
prolonged survival prompted this study. Two hundred selected patients who were operated on
for glioblastoma were reviewed to investigate the incidence of the lymphocytic infiltration ... Cited by 22 - Related articles - All 2 versions
GM Mavligit, EM Hersh, CM McBride - CA A Cancer Journal for … - interscience.wiley.com Tumor-induced blastogenesis was detected in vitro in autologous lymphocytes from 19 of 29
patients with solid tumors. The blastogenic response was dose related, and maximum response
required a tumor cell-lymphocyte ratio of 1:1. The intensity of response correlated ... Cited by 21 - Related articles - All 2 versions
CM Haskell, MJ Silverstein, DM Rangel, JS … - CA A Cancer Journal … - interscience.wiley.com Adriamycin was given by an infra-arterial route as part of a planned program of combined modality
therapy in 10 patients with regionally advanced neoplasms. Doses ranged from 45-107 mg/m
2 given as a continuous infusion over 1.5-3.0 days. Adriamycin was followed by radiation ... Cited by 21 - Related articles
L Nathanson - Cancer Immunology, Immunotherapy, 1977 - Springer Summary. The question of whether host immune factors play a protective role in breast cancer
has been long debated. Early evidence based predominantly on histo- pathologic changes seen
in ipsolateral axillary lymph nodes was suggestive. More recently, the availability of ... Cited by 15 - Related articles
- ►nih.gov [PDF] B Mukherji, L Nathanson, DA Clark - The Yale Journal of Biology …, 1973 - pubmedcentral.nih.gov INTRODUCTION The existence of tumor specific antigens in animal systems has now been well
established and reviewed (1-4). Although definitive proof of the specificity of such antigens in
human tumors has been lacking, there is evidence that tumor associated antigens ... Cited by 10 - Related articles - All 3 versions
- ►nih.gov [PDF] MG Lewis - Journal of Clinical Pathology. Supplement (Royal …, 1974 - pubmedcentral.nih.gov It is impossible to understand the neoplastic process without considering the role of the host.
This is by no means a new or recent concept since host factors were suggested at the turn ofthe
century by a number of observers (Eve, 1903; Handley, 1907; Ehrlich, 1957). The ... Cited by 4 - Related articles - All 6 versions
S Bech-Nielsen, JS Reif, RS Brodey - Vet Radiol, 1976 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 3 - Related articles
